Page 50 - ITPS-8-1

INNOSC Theranostics and
Pharmacological Sciences Ketamine for cocaine use disorder

76. von Diemen L, Kapczinski F, Sordi AO, et al. Increase 86. Woelfer M, Li M, Colic L, et al. Ketamine-induced changes
in brain-derived neurotrophic factor expression in early in plasma brain-derived neurotrophic factor (BDNF)
crack cocaine withdrawal. Int J Neuropsychopharmacol. levels are associated with the resting-state functional
2014;17(1):33-40. connectivity of the prefrontal cortex. World J Biol Psychiatry.
doi: 10.1017/S146114571300103X 2020;21(9):696-710.
77. Corominas-Roso M, Roncero C, Eiroa-Orosa FJ, doi: 10.1080/15622975.2019.1679391
et al. Brain-derived neurotrophic factor serum levels in 87. Haile CN, Murrough JW, Iosifescu DV, et al. Plasma
cocaine-dependent patients during early abstinence. Eur brain derived neurotrophic factor (BDNF) and response
Neuropsychopharmacol. 2013;23(9):1078-1084. to ketamine in treatment-resistant depression. Int J
doi: 10.1016/j.euroneuro.2012.08.016 Neuropsychopharmacol. 2014;17(2):331-336.
78. Le Foll B, Diaz J, Sokoloff P. A single cocaine exposure doi: 10.1017/S1461145713001119
increases BDNF and D3 receptor expression: Implications 88. Berglind WJ, Whitfield TW, LaLumiere RT, Kalivas PW,
for drug-conditioning. Neuroreport. 2005;16(2):175. McGinty JF. A single intra-PFC infusion of BDNF prevents
doi: 10.1097/00001756-200502080-00022 cocaine-induced alterations in extracellular glutamate within
the nucleus accumbens. J Neurosci. 2009;29(12):3715-3719.
79. Ornell F, Hansen F, Schuch FB, et al. Brain-derived
neurotrophic factor in substance use disorders: A systematic doi: 10.1523/JNEUROSCI.5457-08.2009
review and meta-analysis. Drug Alcohol Depend. 89. Schmidt HD, Sangrey GR, Darnell SB, et al. Increased
2018;193:91-103. brain-derived neurotrophic factor (BDNF) expression in
doi: 10.1016/j.drugalcdep.2018.08.036 the ventral tegmental area during cocaine abstinence is
associated with increased histone acetylation at BDNF exon
80. Cavaleri D, Moretti F, Bartoccetti A, et al. The role of BDNF I-containing promoters. J Neurochem. 2012;120(2):202-209.
in major depressive disorder, related clinical features, and
antidepressant treatment: Insight from meta-analyses. doi: 10.1111/j.1471-4159.2011.07571.x
Neurosci Biobehav Rev. 2023;149:105159. 90. McGinty JF, Whitfield TW, Berglind WJ. Brain-derived
doi: 10.1016/j.neubiorev.2023.105159 neurotrophic factor and cocaine addiction. Brain Res.
2010;1314:183-193.
81. Pettorruso M, Miuli A, Clemente K, et al. Enhanced
peripheral levels of BDNF and proBDNF: Elucidating doi: 10.1016/j.brainres.2009.08.078
neurotrophin dynamics in cocaine use disorder. Mol 91. Sarkar A, Kabbaj M. Sex differences in effects of ketamine
Psychiatry. 2024;29(3):760-766. on behavior, spine density, and synaptic proteins in socially
doi: 10.1038/s41380-023-02367-7 isolated rats. Biol Psychiatry. 2016;80(6):448-456.
82. Fonseca F, Mestre-Pinto JI, Rodríguez-Minguela R, et al. doi: 10.1016/j.biopsych.2015.12.025
BDNF and cortisol in the diagnosis of cocaine-induced 92. Thelen C, Sens J, Mauch J, Pandit R, Pitychoutis PM.
depression. Front Psychiatry. 2022;13:836771. Repeated ketamine treatment induces sex-specific
doi: 10.3389/fpsyt.2022.836771 behavioral and neurochemical effects in mice. Behav Brain
Res. 2016;312:305-312.
83. Tooley J, Marconi L, Alipio J, et al. Glutamatergic ventral
pallidal neurons modulate activity of the habenula- doi: 10.1016/j.bbr.2016.06.041
tegmental circuitry and constrain reward seeking. Biol 93. Ponton E, Turecki G, Nagy C. Sex differences in the
Psychiatry. 2018;83(12):1012-1023. behavioral, molecular, and structural effects of ketamine
doi: 10.1016/j.biopsych.2018.01.003 treatment in depression. Int J Neuropsychopharmacol.
2022;25(1):75-84.
84. Viana GSB, Vale EM, Araujo ARA, et al. Rapid and long-
lasting antidepressant-like effects of ketamine and their doi: 10.1093/ijnp/pyab082
relationship with the expression of brain enzymes, BDNF, 94. Saland SK, Schoepfer KJ, Kabbaj M. Hedonic sensitivity to
and astrocytes. Braz J Med Biol Res. 2020;54:e10107.
low-dose ketamine is modulated by gonadal hormones in a
doi: 10.1590/1414-431X202010107 sex-dependent manner. Sci Rep. 2016;6(1):21322.
85. Zheng W, Zhou YL, Wang CY, et al. Plasma BDNF doi: 10.1038/srep21322
concentrations and the antidepressant effects of six 95. Ardalan M, Elfving B, Rafati AH, et al. Rapid effects of
ketamine infusions in unipolar and bipolar depression. S-ketamine on the morphology of hippocampal astrocytes
PeerJ. 2021;9:e10989. and BDNF serum levels in a sex-dependent manner. Eur
doi: 10.7717/peerj.10989 Neuropsychopharmacol. 2020;32:94-103.

Volume 8 Issue 1 (2025) 44 doi: 10.36922/itps.4458